iHub is quite tonight (probably due to the 8K) so
Post# of 148278
Honestly, I’m not excited about the 8K released today. NP keeps talking about non-dilutive financing but here we are. Leronlimab is promising, but if CYDY continues with non-dilutive financing for the BLA and monthly burn, it’s going to get much uglier before it gets pretty.
At this point positive data from the TNBC phase 2 trial is needed to give CYDY a good boost in the interim. Hopefully the 1st patient will initiate the trial in the near future.